Second Affiliated Hospital, School of Medicine, Zhejiang University: Breast Neoplasms trials

The registry lists 29 Breast Neoplasms studies with Second Affiliated Hospital, School of Medicine, Zhejiang University as lead sponsor. 24 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 7Phase 3 3Phase 4 4No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Areola Preservation in NSM With Nipple InvolvementNot yet recruitingNCT07544134Not applicable
• Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by Artificial IntelligenceRecruitingNCT07252986
• A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid TumorsRecruitingNCT07250386Phase 1
• A Study on Predicting the Risk of Distant Metastasis in Breast Cancer Using AI-Generated Spatial Pathological MapsRecruitingNCT07244094
• Neoadjuvant High-Intensity Focused Ultrasound (HIFU) Combined With Toripalimab and Chemotherapy for ER-Positive /HER2-Negative Breast CancerRecruitingNCT06964906Phase 2
• Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate DepressionRecruitingNCT06741540Not applicable
• Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving SurgeryNot yet recruitingNCT06671249Not applicable
• Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast CancerRecruitingNCT06658080
• Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant ChemotherapyRecruitingNCT06596018Phase 1/2
• Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer SurgeryRecruitingNCT06595966
• Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast CancerRecruitingNCT06587789
• Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic ReconstructionRecruitingNCT06464913Phase 2
• Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast CancerNot yet recruitingNCT05841849Phase 4
• Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin RegimenRecruitingNCT05731258
• Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant TherapyRecruitingNCT05649475
• Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)RecruitingNCT05640778Phase 2
• A Study for the Adjuvant Treatment of Breast CancerRecruitingNCT05420467Phase 4
• A Study for the Neoadjuvant Treatment of Breast CancerRecruitingNCT05420454Phase 4
• Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast CancerRecruitingNCT05189067Phase 2/3
• Prophylactic Irradiation to the Contralateral Breast for BCAs PatientsRecruitingNCT04960839Not applicable
• TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)Not yet recruitingNCT04760431Phase 2
• Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast CancerRecruitingNCT04576143Phase 2/3
• Application of Radiomics in Breast CancerRecruitingNCT04483804
• Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast CancerNot yet recruitingNCT04337658Phase 3
• Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor DiagnosisCompletedNCT06172270
• Exploring a Breast Cancer Early Screening Model Based on cfDNACompletedNCT06016790
• Axillary Versus Primary Breast Approach for Second-stage Breast ReconstructionStatus unknownNCT05600153Not applicable
• AC vs TC in Patients With HR-positive, HER2-negative Early Breast CancerStatus unknownNCT05302336Phase 4
• the New Geneswell BCT in Vitro Diagnosis of Breast Cancer PrognosisStatus unknownNCT04179318